Literature DB >> 24081995

Childhood interstitial lung diseases: an 18-year retrospective analysis.

Jennifer J Soares1, Gail H Deutsch, Paul E Moore, Mohammad F Fazili, Eric D Austin, Rebekah F Brown, Andrew G Sokolow, Melissa A Hilmes, Lisa R Young.   

Abstract

OBJECTIVE: Childhood interstitial lung diseases (ILD) occur in a variety of clinical contexts. Advances in the understanding of disease pathogenesis and use of standardized terminology have facilitated increased case ascertainment. However, as all studies have been performed at specialized referral centers, the applicability of these findings to general pulmonary practice has been uncertain. The objective of this study was to determine the historical occurrence of childhood ILD to provide information reflecting general pediatric pulmonary practice patterns.
METHODS: Childhood ILD cases seen at Vanderbilt Children's Hospital from 1994 to 2011 were retrospectively reviewed and classified according to the current pediatric diffuse lung disease histopathologic classification system.
RESULTS: A total of 93 cases were identified, of which 91.4% were classifiable. A total of 68.8% (64/93) of subjects underwent lung biopsy in their evaluations. The largest classification categories were disorders related to systemic disease processes (24.7%), disorders of the immunocompromised host (24.7%), and disorders more prevalent in infancy (22.6%). Eight cases of neuroendocrine cell hyperplasia of infancy (NEHI) were identified, including 5 that were previously unrecognized before this review.
CONCLUSIONS: Our findings demonstrate the general scope of childhood ILD and that these cases present within a variety of pediatric subspecialties. Retrospective review was valuable in recognizing more recently described forms of childhood ILD. As a significant portion of cases were classifiable based on clinical, genetic, and/or radiographic criteria, we urge greater consideration to noninvasive diagnostic approaches and suggest modification to the current childhood ILD classification scheme to accommodate the increasing number of cases diagnosed without lung biopsy.

Entities:  

Keywords:  childhood lung disease; interstitial lung disease; lung biopsy

Mesh:

Year:  2013        PMID: 24081995      PMCID: PMC3784299          DOI: 10.1542/peds.2013-1780

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

1.  A mutation in the surfactant protein C gene associated with familial interstitial lung disease.

Authors:  L M Nogee; A E Dunbar; S E Wert; F Askin; A Hamvas; J A Whitsett
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

2.  Factors influencing survival in children with chronic interstitial lung disease.

Authors:  L L Fan; C A Kozinetz
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

3.  Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis.

Authors:  L M Nogee; D E de Mello; L P Dehner; H R Colten
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

4.  Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders.

Authors:  Lisa R Young; Alan S Brody; Thomas H Inge; James D Acton; Ronald E Bokulic; Claire Langston; Gail H Deutsch
Journal:  Chest       Date:  2010-09-30       Impact factor: 9.410

5.  Pediatric diffuse lung disease: diagnosis and classification using high-resolution CT.

Authors:  D A Lynch; T Hay; J D Newell; V D Divgi; L L Fan
Journal:  AJR Am J Roentgenol       Date:  1999-09       Impact factor: 3.959

Review 6.  Genetic disorders of surfactant dysfunction.

Authors:  Susan E Wert; Jeffrey A Whitsett; Lawrence M Nogee
Journal:  Pediatr Dev Pathol       Date:  2009 Jul-Aug

Review 7.  Evaluating infants and children with interstitial lung disease.

Authors:  Robin Deterding
Journal:  Semin Respir Crit Care Med       Date:  2007-06       Impact factor: 3.119

8.  Imaging of Childhood Interstitial Lung Disease.

Authors:  R Paul Guillerman
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

9.  Clinical spectrum of chronic interstitial lung disease in children.

Authors:  L L Fan; A L Mullen; S M Brugman; S C Inscore; D P Parks; C W White
Journal:  J Pediatr       Date:  1992-12       Impact factor: 4.406

10.  ABCA3 gene mutations in newborns with fatal surfactant deficiency.

Authors:  Sergey Shulenin; Lawrence M Nogee; Tarmo Annilo; Susan E Wert; Jeffrey A Whitsett; Michael Dean
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

View more
  20 in total

1.  Rare Becomes More Common: Recognizing Neuroendocrine Cell Hyperplasia of Infancy in Everyday Pulmonary Consultations.

Authors:  Michael Glenn O'Connor; Mark Wurth; Lisa R Young
Journal:  Ann Am Thorac Soc       Date:  2015-11

2.  Lung and airway shape in neuroendocrine cell hyperplasia of infancy.

Authors:  Emily J Mastej; Emily M DeBoer; Stephen M Humphries; Marlijne C Cook; Kendall S Hunter; Deborah R Liptzin; Jason P Weinman; Robin R Deterding
Journal:  Pediatr Radiol       Date:  2018-06-28

Review 3.  Interstitial lung disease in children.

Authors:  Christin S Kuo; Lisa R Young
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

4.  "A remarkable experience of god, shaping us as a family": parents' use of faith following child's rare disease diagnosis.

Authors:  Hillary N Purcell; Allison Whisenhunt; Joy Cheng; Sophia Dimitriou; Lisa R Young; Daniel H Grossoehme
Journal:  J Health Care Chaplain       Date:  2015

5.  Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme.

Authors:  Leland L Fan; Megan K Dishop; Csaba Galambos; Frederic B Askin; Frances V White; Claire Langston; Deborah R Liptzin; Miranda E Kroehl; Gail H Deutsch; Lisa R Young; Geoffrey Kurland; James Hagood; Sharon Dell; Bruce C Trapnell; Robin R Deterding
Journal:  Ann Am Thorac Soc       Date:  2015-10

Review 6.  Interstitial lung disease in newborns.

Authors:  Lawrence M Nogee
Journal:  Semin Fetal Neonatal Med       Date:  2017-03-28       Impact factor: 3.926

Review 7.  Approaching Clinical Trials in Childhood Interstitial Lung Disease and Pediatric Pulmonary Fibrosis.

Authors:  Robin R Deterding; Emily M DeBoer; Michal J Cidon; Terry E Robinson; David Warburton; Gail H Deutsch; Lisa R Young
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

8.  Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD.

Authors:  Saliha Esenboga; Nagehan Emiralioglu; Deniz Cagdas; Baran Erman; Martin De Boer; Berna Oguz; Nural Kiper; İlhan Tezcan
Journal:  J Clin Immunol       Date:  2017-02-21       Impact factor: 8.317

9.  Growth trajectories and oxygen use in neuroendocrine cell hyperplasia of infancy.

Authors:  Rebekah J Nevel; Errine T Garnett; Deneen A Schaudies; Lisa R Young
Journal:  Pediatr Pulmonol       Date:  2018-02-02

10.  Persistent Lung Disease in Adults with NKX2.1 Mutation and Familial Neuroendocrine Cell Hyperplasia of Infancy.

Authors:  Rebekah J Nevel; Errine T Garnett; John A Worrell; Ronald L Morton; Lawrence M Nogee; Timothy S Blackwell; Lisa R Young
Journal:  Ann Am Thorac Soc       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.